Your browser doesn't support javascript.
loading
Case Report: Neoadjuvant and Adjuvant Crizotinib Targeted Therapy in Stage IIIA-N2 ALK-Positive Non-Small-Cell Lung Cancer.
Xie, Xiao-Hong; Zhan, Ze-Jiang; Qin, Yin-Yin; Jiang, Ju-Hong; Yin, Wei-Qiang; Zheng, Rong-Hui; Li, Shi-Yue; Zhou, Cheng-Zhi.
Afiliação
  • Xie XH; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou, China.
  • Zhan ZJ; Guangzhou Medical University, Guangzhou, China.
  • Qin YY; Guangzhou Medical University, Guangzhou, China.
  • Jiang JH; Department of Radiation Oncology, The Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China.
  • Yin WQ; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou, China.
  • Zheng RH; Guangzhou Medical University, Guangzhou, China.
  • Li SY; Guangzhou Medical University, Guangzhou, China.
  • Zhou CZ; Department of Respiratory Pathology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou, China.
Front Oncol ; 11: 655856, 2021.
Article em En | MEDLINE | ID: mdl-33816312
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2021 Tipo de documento: Article